Patients with low tumor burden as defined by ISS stages I and II at start of treatment appeared to gain increased benefit compared to those with stage III disease, confirming our previous observation (Danhof et al. treatment cycles. Median PFS was 6.4?months with 12-month and 18-month PFS rates of 35% […]
Daily Archives: June 23, 2022
1 post